Community Practice

If a pharmacist has to hide what he is doing, then maybe he shouldn't be practicing pharmacy.

You can own your own pharmacy, and it can give you a fulfilling life. But you gotta play the angles.

New Rx, generics, and OTC for pharmacists

From reader Bill Tarr comes the second article in Drug Topics' new series, Pathways through Pharmacy. While the first signs of his professional direction may have come as something of a surprise, he rose to the challenge and found that it gave him a vehicle for the good life.

California is considering changes to state law designed to make the labels on prescription drug containers easier to understand.

Physician Assistants. Nurse Practitioners. Nurse Clinicians. Nurse Anesthetists. Need we say more?

Cannabis extracts show strong potential for treatment of various medical conditions. The same cannot be said about smoked marijuana. Here are a few of the reasons.

The most powerful drug in your pharmacy is not what you may think.

An educational video, released at the National Association of Boards of Pharmacy annual meeting in May, helps pharmacists identify the ‘red flags’ of prescription drug abuse and diversion when they dispense controlled substances.

Pharmacists can play a significant role in advocating for the screening and treatment of this disease state. They are in a unique position to improve patient outcomes in late-life depression.

The following comes to you courtesy of someone who wishes she’d had this list three months ago …One day you wake up and go to your job, and the next day you don’t have a job to go to. It can be that simple and that complicated, but the real question is, WHAT DO I DO NOW?

Advocacy issues discussed at the conference included two pieces of proposed legislation that would affect compensation for pharmacists and collaborative practice agreements between pharmacists and physicians.

A brief video, accessed by prescription label QR code scanned with a smartphone, instructs patients in proper drug use and much more.

Now more than ever, action by Congress and CMS is needed to alleviate beneficiaries' concerns about access to pharmacies of their choice.

A subanalysis of the Phase 3 ARISTOTLE trial indicates that apixaban reduces the risk of stroke regardless of whether a patient’s blood pressure is controlled.

Medication adherence suffers when patients do not understand dose or use instructions. Pharmacists can use multisensory tools to help patients learn and remember.

New Rx, new generics, and new OTC

Fifty years ago, advertisers said cigarettes were good for you. Nobody believes that anymore. Maybe 50 years from now, no one will think it's okay for cigarettes to be sold in pharmacies.

Five simple words. Here they are.

This pharmacist's decision to follow her bliss has made countless patients a whole lot happier.

Using verbal, written, and visual communication strategies, pharmacists can empower patients with limited health literacy to manage complex medication regimens.

FDA approves a powder delivery system combining a corticosteroid and a LABA.

Extra points if you can use the word "bone-headed" in your answer.

Since pharmacists dispense potentially harmful medications, it is critical that we also impart information about poison control.

Pharmacies often overlook their licensing requirements or fail to discover the extent to which a license is required for a particular activity. Not good.

Letters, e-mails, comments, and posts from Drug Topics readers

Hours after we posted Kim Ankenbruck's “A dose of pharmacy truth: Report from the front lines,” the responses started showing up. Here's a collection of the early returns.

Patients who use statins are consuming more calories and fats than a decade earlier, increasing the risk of obesity, diabetes, and cardiovascular disease, according to a study published online in JAMA Internal Medicine.

Who sez older pharmacists should be put out to pasture? Not these guys - they're too busy working to consider the possibility.

FDA Commissioner Margaret A. Hamburg, MD, defended the agency’s approval of the powerful opioid Zohydro ER (hydrocodone bitartrate) extended-release capsules, explaining that its highest dose is no more potent than the highest strengths of the opioid OxyContin ER (oxycodone) extended-release and extended-release morphine, in an FDA blog posted April 29.